APEX | Robust | Detects only known variants |
| Versatile (addition of new variants with little extra costs) | Low efficiency in early stages |
| Cheap (<€200) | Less efficient for analysing patients of other ethnic backgrounds |
| Medium throughput | Requires specialised expertise |
| Not highly dependent on DNA quality | Sequence confirmation required |
Sequence analysis | Robust | High costs (>€1000 for MYO7A or USH2A) |
| Versatile | |
| Easy set-up | |
Capillary-based heteroduplex | Robust | Polymorphic sequences difficult to analyse |
analysis | Medium throughput | Sequence analysis necessary for mutation identification |
| Relatively cheap | |
Resequencing (Affymetrix) | Fully automated | High costs (∼€600) |
| Detects known and new nucleotide substitutions | No detection of heterozygous deletions >1 nt and all duplications/insertions (47/292 (16%) pathologic USH variants) |
| | Addition of tested genes requires new chip design |